Drug
Humax Cd4
Humax Cd4: highest development phase Phase 2/3, developed by Emergent BioSolutions, Genmab. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Emergent BioSolutions, Genmab
Trials
| Drug | Phase | Indication |
|---|---|---|
| HuMax-CD4 NCT00877656 | Phase 2/3 | T Cell Lymphoma |
| HuMax-CD4 NCT00071084 | Phase 2 | Cutaneous T-Cell Lymphoma |
Latest
No recent events.
Follow Humax Cd4 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.